Case No.

Sex

Age (yr)

Duration (yr)

A1c (%)

Complications and associated disease

Barriers**

1

M

46

9

11.9

chronic hepatitis

1,5

2

F

60

11

8.4

nephropathy, hypertension

1,4

3

M

52

9

9.3

hypertension

1

4

F

54

16

9.4

hypertension

1,4,5

5

M

58

12

11.7

retinopathy

2,5

6

F

70

9

12.4

neuropathy,

4

7

F

71

20

9.8

retinopathy

5

8

F

57

6

11.2

NA*

2,5

9

F

64

16

12.5

neuropathy

2,3,5

10

M

68

15

10.8

neuropathy

2,5

11

F

65

2

10.6

NA*

5

12

F

58

10

12.5

retinopathy

4,5

13

F

62

10

11.4

NA*

3

14

F

51

8

12

NA*

2,3

15

M

65

10

11

Nephropathy, retinopathy

1,3
NA*: not recorded. Barriers**: 1 = reluctance of physicians, 2 = misconceptions about insulin, 3 = low adaptation capacity, 4 = needle phobia and 5 = psychological insulin resistance
Table 1: Clinical characteristics and barriers of insulin treatment of the people with type 2 diabetes who reluctant to insulin therapy.